Request for Covid-19 Impact Assessment of this Report
The United States Vasopressin V1b Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vasopressin V1b Receptor market, reaching US$ million by the year 2028. As for the Europe Vasopressin V1b Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vasopressin V1b Receptor players cover AbbVie Inc., Allergan Plc, Azevan Pharmaceuticals, Inc., and Laboratorio ELEA S.A.C.I.F. y A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vasopressin V1b Receptor market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
PHT-103
ABT-436
AVN-628
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie Inc.
Allergan Plc
Azevan Pharmaceuticals, Inc.
Laboratorio ELEA S.A.C.I.F. y A.
Orphan Therapeutics, LLC
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vasopressin V1b Receptor Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vasopressin V1b Receptor by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vasopressin V1b Receptor by Country/Region, 2017, 2022 & 2028
2.2 Vasopressin V1b Receptor Segment by Type
2.2.1 PHT-103
2.2.2 ABT-436
2.2.3 AVN-628
2.2.4 Others
2.3 Vasopressin V1b Receptor Sales by Type
2.3.1 Global Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
2.3.2 Global Vasopressin V1b Receptor Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vasopressin V1b Receptor Sale Price by Type (2017-2022)
2.4 Vasopressin V1b Receptor Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Vasopressin V1b Receptor Sales by Application
2.5.1 Global Vasopressin V1b Receptor Sale Market Share by Application (2017-2022)
2.5.2 Global Vasopressin V1b Receptor Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vasopressin V1b Receptor Sale Price by Application (2017-2022)
3 Global Vasopressin V1b Receptor by Company
3.1 Global Vasopressin V1b Receptor Breakdown Data by Company
3.1.1 Global Vasopressin V1b Receptor Annual Sales by Company (2020-2022)
3.1.2 Global Vasopressin V1b Receptor Sales Market Share by Company (2020-2022)
3.2 Global Vasopressin V1b Receptor Annual Revenue by Company (2020-2022)
3.2.1 Global Vasopressin V1b Receptor Revenue by Company (2020-2022)
3.2.2 Global Vasopressin V1b Receptor Revenue Market Share by Company (2020-2022)
3.3 Global Vasopressin V1b Receptor Sale Price by Company
3.4 Key Manufacturers Vasopressin V1b Receptor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vasopressin V1b Receptor Product Location Distribution
3.4.2 Players Vasopressin V1b Receptor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vasopressin V1b Receptor by Geographic Region
4.1 World Historic Vasopressin V1b Receptor Market Size by Geographic Region (2017-2022)
4.1.1 Global Vasopressin V1b Receptor Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vasopressin V1b Receptor Annual Revenue by Geographic Region
4.2 World Historic Vasopressin V1b Receptor Market Size by Country/Region (2017-2022)
4.2.1 Global Vasopressin V1b Receptor Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vasopressin V1b Receptor Annual Revenue by Country/Region
4.3 Americas Vasopressin V1b Receptor Sales Growth
4.4 APAC Vasopressin V1b Receptor Sales Growth
4.5 Europe Vasopressin V1b Receptor Sales Growth
4.6 Middle East & Africa Vasopressin V1b Receptor Sales Growth
5 Americas
5.1 Americas Vasopressin V1b Receptor Sales by Country
5.1.1 Americas Vasopressin V1b Receptor Sales by Country (2017-2022)
5.1.2 Americas Vasopressin V1b Receptor Revenue by Country (2017-2022)
5.2 Americas Vasopressin V1b Receptor Sales by Type
5.3 Americas Vasopressin V1b Receptor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vasopressin V1b Receptor Sales by Region
6.1.1 APAC Vasopressin V1b Receptor Sales by Region (2017-2022)
6.1.2 APAC Vasopressin V1b Receptor Revenue by Region (2017-2022)
6.2 APAC Vasopressin V1b Receptor Sales by Type
6.3 APAC Vasopressin V1b Receptor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vasopressin V1b Receptor by Country
7.1.1 Europe Vasopressin V1b Receptor Sales by Country (2017-2022)
7.1.2 Europe Vasopressin V1b Receptor Revenue by Country (2017-2022)
7.2 Europe Vasopressin V1b Receptor Sales by Type
7.3 Europe Vasopressin V1b Receptor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vasopressin V1b Receptor by Country
8.1.1 Middle East & Africa Vasopressin V1b Receptor Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vasopressin V1b Receptor Revenue by Country (2017-2022)
8.2 Middle East & Africa Vasopressin V1b Receptor Sales by Type
8.3 Middle East & Africa Vasopressin V1b Receptor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vasopressin V1b Receptor
10.3 Manufacturing Process Analysis of Vasopressin V1b Receptor
10.4 Industry Chain Structure of Vasopressin V1b Receptor
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vasopressin V1b Receptor Distributors
11.3 Vasopressin V1b Receptor Customer
12 World Forecast Review for Vasopressin V1b Receptor by Geographic Region
12.1 Global Vasopressin V1b Receptor Market Size Forecast by Region
12.1.1 Global Vasopressin V1b Receptor Forecast by Region (2023-2028)
12.1.2 Global Vasopressin V1b Receptor Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vasopressin V1b Receptor Forecast by Type
12.7 Global Vasopressin V1b Receptor Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc.
13.1.1 AbbVie Inc. Company Information
13.1.2 AbbVie Inc. Vasopressin V1b Receptor Product Offered
13.1.3 AbbVie Inc. Vasopressin V1b Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Inc. Main Business Overview
13.1.5 AbbVie Inc. Latest Developments
13.2 Allergan Plc
13.2.1 Allergan Plc Company Information
13.2.2 Allergan Plc Vasopressin V1b Receptor Product Offered
13.2.3 Allergan Plc Vasopressin V1b Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Allergan Plc Main Business Overview
13.2.5 Allergan Plc Latest Developments
13.3 Azevan Pharmaceuticals, Inc.
13.3.1 Azevan Pharmaceuticals, Inc. Company Information
13.3.2 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Offered
13.3.3 Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Azevan Pharmaceuticals, Inc. Main Business Overview
13.3.5 Azevan Pharmaceuticals, Inc. Latest Developments
13.4 Laboratorio ELEA S.A.C.I.F. y A.
13.4.1 Laboratorio ELEA S.A.C.I.F. y A. Company Information
13.4.2 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Offered
13.4.3 Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Laboratorio ELEA S.A.C.I.F. y A. Main Business Overview
13.4.5 Laboratorio ELEA S.A.C.I.F. y A. Latest Developments
13.5 Orphan Therapeutics, LLC
13.5.1 Orphan Therapeutics, LLC Company Information
13.5.2 Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Offered
13.5.3 Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Orphan Therapeutics, LLC Main Business Overview
13.5.5 Orphan Therapeutics, LLC Latest Developments
14 Research Findings and Conclusion
Table 1. Vasopressin V1b Receptor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vasopressin V1b Receptor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of PHT-103
Table 4. Major Players of ABT-436
Table 5. Major Players of AVN-628
Table 6. Major Players of Others
Table 7. Global Vasopressin V1b Receptor Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
Table 9. Global Vasopressin V1b Receptor Revenue by Type (2017-2022) & ($ million)
Table 10. Global Vasopressin V1b Receptor Revenue Market Share by Type (2017-2022)
Table 11. Global Vasopressin V1b Receptor Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Vasopressin V1b Receptor Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Table 14. Global Vasopressin V1b Receptor Revenue by Application (2017-2022)
Table 15. Global Vasopressin V1b Receptor Revenue Market Share by Application (2017-2022)
Table 16. Global Vasopressin V1b Receptor Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Vasopressin V1b Receptor Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Vasopressin V1b Receptor Sales Market Share by Company (2020-2022)
Table 19. Global Vasopressin V1b Receptor Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Vasopressin V1b Receptor Revenue Market Share by Company (2020-2022)
Table 21. Global Vasopressin V1b Receptor Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Vasopressin V1b Receptor Producing Area Distribution and Sales Area
Table 23. Players Vasopressin V1b Receptor Products Offered
Table 24. Vasopressin V1b Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vasopressin V1b Receptor Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Vasopressin V1b Receptor Sales Market Share Geographic Region (2017-2022)
Table 29. Global Vasopressin V1b Receptor Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Vasopressin V1b Receptor Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Vasopressin V1b Receptor Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Vasopressin V1b Receptor Sales Market Share by Country/Region (2017-2022)
Table 33. Global Vasopressin V1b Receptor Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Vasopressin V1b Receptor Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Vasopressin V1b Receptor Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Vasopressin V1b Receptor Sales Market Share by Country (2017-2022)
Table 37. Americas Vasopressin V1b Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Vasopressin V1b Receptor Revenue Market Share by Country (2017-2022)
Table 39. Americas Vasopressin V1b Receptor Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
Table 41. Americas Vasopressin V1b Receptor Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Table 43. APAC Vasopressin V1b Receptor Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Vasopressin V1b Receptor Sales Market Share by Region (2017-2022)
Table 45. APAC Vasopressin V1b Receptor Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Vasopressin V1b Receptor Revenue Market Share by Region (2017-2022)
Table 47. APAC Vasopressin V1b Receptor Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
Table 49. APAC Vasopressin V1b Receptor Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Table 51. Europe Vasopressin V1b Receptor Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Vasopressin V1b Receptor Sales Market Share by Country (2017-2022)
Table 53. Europe Vasopressin V1b Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Vasopressin V1b Receptor Revenue Market Share by Country (2017-2022)
Table 55. Europe Vasopressin V1b Receptor Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
Table 57. Europe Vasopressin V1b Receptor Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Vasopressin V1b Receptor Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Vasopressin V1b Receptor Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vasopressin V1b Receptor Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Vasopressin V1b Receptor Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Vasopressin V1b Receptor Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Vasopressin V1b Receptor Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Vasopressin V1b Receptor Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Vasopressin V1b Receptor
Table 68. Key Market Challenges & Risks of Vasopressin V1b Receptor
Table 69. Key Industry Trends of Vasopressin V1b Receptor
Table 70. Vasopressin V1b Receptor Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Vasopressin V1b Receptor Distributors List
Table 73. Vasopressin V1b Receptor Customer List
Table 74. Global Vasopressin V1b Receptor Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Vasopressin V1b Receptor Sales Market Forecast by Region
Table 76. Global Vasopressin V1b Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Vasopressin V1b Receptor Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Vasopressin V1b Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Vasopressin V1b Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Vasopressin V1b Receptor Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Vasopressin V1b Receptor Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Vasopressin V1b Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Vasopressin V1b Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Vasopressin V1b Receptor Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Vasopressin V1b Receptor Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Vasopressin V1b Receptor Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Vasopressin V1b Receptor Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Vasopressin V1b Receptor Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Vasopressin V1b Receptor Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Vasopressin V1b Receptor Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Vasopressin V1b Receptor Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Vasopressin V1b Receptor Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Vasopressin V1b Receptor Revenue Market Share Forecast by Application (2023-2028)
Table 94. AbbVie Inc. Basic Information, Vasopressin V1b Receptor Manufacturing Base, Sales Area and Its Competitors
Table 95. AbbVie Inc. Vasopressin V1b Receptor Product Offered
Table 96. AbbVie Inc. Vasopressin V1b Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. AbbVie Inc. Main Business
Table 98. AbbVie Inc. Latest Developments
Table 99. Allergan Plc Basic Information, Vasopressin V1b Receptor Manufacturing Base, Sales Area and Its Competitors
Table 100. Allergan Plc Vasopressin V1b Receptor Product Offered
Table 101. Allergan Plc Vasopressin V1b Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Allergan Plc Main Business
Table 103. Allergan Plc Latest Developments
Table 104. Azevan Pharmaceuticals, Inc. Basic Information, Vasopressin V1b Receptor Manufacturing Base, Sales Area and Its Competitors
Table 105. Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Product Offered
Table 106. Azevan Pharmaceuticals, Inc. Vasopressin V1b Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Azevan Pharmaceuticals, Inc. Main Business
Table 108. Azevan Pharmaceuticals, Inc. Latest Developments
Table 109. Laboratorio ELEA S.A.C.I.F. y A. Basic Information, Vasopressin V1b Receptor Manufacturing Base, Sales Area and Its Competitors
Table 110. Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Product Offered
Table 111. Laboratorio ELEA S.A.C.I.F. y A. Vasopressin V1b Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Laboratorio ELEA S.A.C.I.F. y A. Main Business
Table 113. Laboratorio ELEA S.A.C.I.F. y A. Latest Developments
Table 114. Orphan Therapeutics, LLC Basic Information, Vasopressin V1b Receptor Manufacturing Base, Sales Area and Its Competitors
Table 115. Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Offered
Table 116. Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Orphan Therapeutics, LLC Main Business
Table 118. Orphan Therapeutics, LLC Latest Developments
List of Figures
Figure 1. Picture of Vasopressin V1b Receptor
Figure 2. Vasopressin V1b Receptor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vasopressin V1b Receptor Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Vasopressin V1b Receptor Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vasopressin V1b Receptor Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of PHT-103
Figure 10. Product Picture of ABT-436
Figure 11. Product Picture of AVN-628
Figure 12. Product Picture of Others
Figure 13. Global Vasopressin V1b Receptor Sales Market Share by Type in 2021
Figure 14. Global Vasopressin V1b Receptor Revenue Market Share by Type (2017-2022)
Figure 15. Vasopressin V1b Receptor Consumed in Hospital
Figure 16. Global Vasopressin V1b Receptor Market: Hospital (2017-2022) & (K Pcs)
Figure 17. Vasopressin V1b Receptor Consumed in Clinic
Figure 18. Global Vasopressin V1b Receptor Market: Clinic (2017-2022) & (K Pcs)
Figure 19. Vasopressin V1b Receptor Consumed in Others
Figure 20. Global Vasopressin V1b Receptor Market: Others (2017-2022) & (K Pcs)
Figure 21. Global Vasopressin V1b Receptor Sales Market Share by Application (2017-2022)
Figure 22. Global Vasopressin V1b Receptor Revenue Market Share by Application in 2021
Figure 23. Vasopressin V1b Receptor Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Vasopressin V1b Receptor Revenue Market Share by Company in 2021
Figure 25. Global Vasopressin V1b Receptor Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Vasopressin V1b Receptor Revenue Market Share by Geographic Region in 2021
Figure 27. Global Vasopressin V1b Receptor Sales Market Share by Region (2017-2022)
Figure 28. Global Vasopressin V1b Receptor Revenue Market Share by Country/Region in 2021
Figure 29. Americas Vasopressin V1b Receptor Sales 2017-2022 (K Pcs)
Figure 30. Americas Vasopressin V1b Receptor Revenue 2017-2022 ($ Millions)
Figure 31. APAC Vasopressin V1b Receptor Sales 2017-2022 (K Pcs)
Figure 32. APAC Vasopressin V1b Receptor Revenue 2017-2022 ($ Millions)
Figure 33. Europe Vasopressin V1b Receptor Sales 2017-2022 (K Pcs)
Figure 34. Europe Vasopressin V1b Receptor Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Vasopressin V1b Receptor Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Vasopressin V1b Receptor Revenue 2017-2022 ($ Millions)
Figure 37. Americas Vasopressin V1b Receptor Sales Market Share by Country in 2021
Figure 38. Americas Vasopressin V1b Receptor Revenue Market Share by Country in 2021
Figure 39. United States Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Vasopressin V1b Receptor Sales Market Share by Region in 2021
Figure 44. APAC Vasopressin V1b Receptor Revenue Market Share by Regions in 2021
Figure 45. China Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Vasopressin V1b Receptor Sales Market Share by Country in 2021
Figure 52. Europe Vasopressin V1b Receptor Revenue Market Share by Country in 2021
Figure 53. Germany Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Vasopressin V1b Receptor Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Vasopressin V1b Receptor Revenue Market Share by Country in 2021
Figure 60. Egypt Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Vasopressin V1b Receptor Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Vasopressin V1b Receptor in 2021
Figure 66. Manufacturing Process Analysis of Vasopressin V1b Receptor
Figure 67. Industry Chain Structure of Vasopressin V1b Receptor
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...